ELEM is a biosimulation company developing Healthcare Digital Twins that help pharmaceutical and medical device companies test, predict and understand treatment outcomes before they reach patients.
Mission
Vision
Why ELEM?
Biosimulation company values
Scientific Rigour
We actively advance biosimulation and biomedical research by publishing in peer-reviewed journals, presenting at leading conferences and contributing to global research collaborations.
Equity and access
Our healthcare digital twins reduce reliance on animals, enable safe trials in rare and high-risk conditions, and create new opportunities for more inclusive and ethical studies.
Advanced
Our biosimulation technology combines biomedical science, multiscale and multiphysics mechanistic modelling, AI and high-performance computing to replicate complex human physiology.
Collaboration
Our PhD-level scientists and engineers partner with clinicians, therapeutic companies, and trial experts to replicate real-world studies and produce validated evidence.
Meticulous validation
Every result we deliver is backed by validated data, transparent versioning and rigorous scientific methodology
Biosimulation multidisciplinary team
Founders & Board
Christopher Morton
Founders & Board
Mariano Vázquez
Co-Founder
Guillaume Houzeaux
Co-Founder
José María Cela
Board Member
Romain Micol, MD
Board Member
Jo Pisani
Board Member
Roger Assaker
Translational Systems Physiology
Tinen Iles, PhD
Cardiac Computational Modelling
Blanca Rodríguez, PhD
Cardiac Imaging and Function
Francesc Carreras Costa, MD
Senior Scientist
Jose María Guerra Ramos, MD
Electrophysiology, Arrhythmia
David Filgueiras Rama, MD
Otorhinolaryngology and Head and Neck Surgery
Cristóbal Langdon, MD
Translational Systems Physiology
Paul Iaizzo, MD
Signal and image processing
Oscar Camara, PhD